I’m excited to share our Cryolipolysis And Ems system, built for clinics and OEM partners seeking reliable aesthetics tech. We offer ODM options and can tailor the Product line to your brand. This dual-action machine combines cryolipolysis and EMS (electrical muscle stimulation) to sculpt fat and tone muscles in a single session, with minimal downtime. Precise temperature control, safe paddles, and adjustable suction help deliver consistent results across body areas. As a B2B partner, I can tailor cartridges, handpieces, and software to your needs, including packaging and after-sales support. The compact footprint fits tight clinics and studios, ideal for med-spas expanding their services. If ODM collaboration is what you’re after, this {Cryolipolysis And Ems} platform can scale with your brand and growth targets.
Cryolipolysis targets fat by controlled cooling, while EMS tones muscle with electrical stimulation. When combined in one platform, they form a fast, non-invasive body contouring solution that can shorten treatment times and improve outcomes. In a global market, this dual action differentiates offerings with proven results and quick patient recovery. For global procurement, focus on reliability, safety, and maintenance. Key features include precise temperature control, patient sensors, flexible protocols, and scalable hardware. Look for modular design, global power compatibility, multilingual interfaces, and comprehensive training and after-sales support to ensure strong ROI.
| Dimension | Cryolipolysis | EMS | Laser Lipolysis | Radiofrequency Therapy |
|---|---|---|---|---|
| Typical treatment duration (minutes) | 35–60 | 20–40 | 30–60 | 20–40 |
| Downtime (days) | 0–2 | 0 | 0 | 0 |
| Pain during treatment (0–10) | 2–5 | 1–3 | 3–6 | 2–4 |
| Typical courses to see results | 1–3 sessions | 6–12 weeks, 2–3x/week | 1–4 sessions | 4–8 sessions |
| Fat reduction / body composition change | 20–25% per treated area | 0–2% fat reduction (primarily muscle gain) | 15–25% | 10–20% |
| Time to noticeable results | 1–3 months | 6–12 weeks | 1–2 months | 1–3 months |
| Return to normal activities | 0–2 days | Same day | Same day | Same day |
| Patient satisfaction (0–100) | 70–85 | 60–75 | 65–80 | 60–75 |
| Safety incidents (per 1000 sessions) | 0.5–2 | 0–1 | 0–1 | 0–1.5 |
| FDA-cleared status | Yes | Yes | Yes | Yes |